ARCHIVES

Cancer Center Lineup complete: 11 Renewals, Funding Continued for Three, Two Unfunded

This article is from The Cancer Letter archive.

Vol. 16 No. 37 | September 28, 1990

Download PDF Visit The Full Archive

Related Articles

MIT Researcher Ingested P-32; NRC Investigating

October 27, 1995

Counter-Point: George Sledge Responds To Berry’s Letter: Neoadjuvant Doesn’t Predict Adjuvant In Breast Cancer

July 11, 2014

Taxol Issue Prompts Questions Forom Reader

July 26, 1991

Former NCI, FDA Chief Andrew Von Eschenbach Appointed to NCCN Foundation Board

June 17, 2011

Text of concept statement included in this 8-page issue.

July 16, 2004

After Year-Long Review, Varmus Removes “Reasonable Pricing” Clause From CRADA

April 14, 1995